AUAUniversity

AUA Urology Core Curriculum: auau.auanet.org/core Host: Jay D. Raman, MD, FACS Co-Host: Adrien Bernstein, MD Outline: 1. The aging population and their unique needs 2. Geriatric Assessment 3. Practical applications of geriatric centered surgical care 4. Palliative care as part of Geriatric oncology

Host: Jay D. Raman, MD, FACS Guest: A. Lenore Ackerman, MD, PhD For more information or to subscribe to the AUA Update Series, please visit: AUAnet.org/University

AUA Urology Core Curriculum: https://auau.auanet.org/core Host: Jay D. Raman, MD, FACS Co-Host: Zachary Klaassen, MD, MSC Outline: 1. Understand the importance of Cancer Survivorship Plans 2. Mental Health Among GU Cancer Survivors 3. Importance of understanding financial toxicity 4. Prostate Cancer 5. Bladder Cancer 6. Kidney cancer 7. Testicular Cancer

Advancing Equitable Opportunities for Recruitment of Diverse Patients to Clinical Trials (Race, Ethnicity, Women, Older Patients) CME Available: https://auau.auanet.org/node/35728 Moderator: Jay D. Raman, MD, FACS Co-Hosts: Adam Murphy, MD, MBA, MSCI; Sarah Psutka, MD, MS ACKNOWLEDGEMENTS This educational series is supported by independent educational grants from: Astellas AstraZeneca Bayer Jansse...

AUA Urology Core Curriculum: https://auau.auanet.org/core Host: Jay D. Raman, MD, FACS Co-Host: Marcelino E. Rivera, MD Outline: 1. Acute stone event and Radiographic evaluation 2. Shock Wave Lithotripsy 3. Ureteroscopy 4. Percutaneous Nephrolithotomy 5. Intracorporeal Lithotripsy 6. Special considerations

AUA Urology Core Curriculum: https://auau.auanet.org/core Host: Jay D. Raman, MD, FACS Co-Host: Maurice M. Garcia, MD, MAS Outline: Segment #1 Topic: How did you get into the field of transgender surgery? Segment #2 Topic: Tell us about the patients who come to you for surgery. Who are they? Segment #3 Topic Overview of feminizing genital GAS. Segment #4 Topic: Overview of masculinizing genital GA...

Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer (2022) CME Available: https://auau.auanet.org/node/36089 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Differentiate among the subtypes of kidney cancer, with emphasis on clinical management decisions, and outline ways in which knowledge of kidney cancer subtypes can alter su...

Operationalizing Checkpoint Inhibitors in Urologic Practice (2022) CME Available: https://auau.auanet.org/node/36084 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Discuss how to develop a structured approach for administering checkpoint inhibitors in urologic practice as part of a structured program. 2. Manage adverse events from checkpoint inhibitors 3. Id...

Financial Toxicity as Drugs Move Earlier into Treatment Paradigm and How This Relates to Disparities in Treatment Patterns CME Available: https://auau.auanet.org/node/35729 Moderator: Jay D. Raman, MD, FACS Co-Hosts: Sarah Psutka, MD, MS LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Define the magnitude of financial toxicity/economic implications across G...

Incorporating Genomic Testing for Prostate Cancer into Your Practice (2022) CME Available: https://auau.auanet.org/node/36074 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Discuss the research studies that led to the approval of genomic testing for prostate cancer 2. Order appropriate genomic testing based on a patient's unique clinical situation 3. State t...

Refractory Overactive Bladder: How to Select 3rd-Line Therapies and Optimize Outcomes (2022) CME Available: https://auau.auanet.org/node/36033 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Describe the various 3rd line therapies available to treat refractory overactive bladder (OAB) and be able to discuss the pros and cons of each of the 3rd line therapies...

Bladder Cancer Treatment Dilemmas: The Cases You Face and What To Do about Them (2022) CME Available: https://auau.auanet.org/node/36049 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Assign risk stratification to patients with bladder cancer. 2. Adapt treatment choices depending on risk of disease and availability of bacillus Calmette-Guérin (BCG). 3. Indiv...

Genetic Testing in Prostate Cancer: Clinical Implications for Early Detection and Management of Localized and Advanced Disease Webcast (2022) CME Available: https://auau.auanet.org/node/36044 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Counsel men with BRCA1/2 mutations, Lynch syndrome, and other key inherited syndromes regarding their prostate cancer ris...

CME Available: https://auau.auanet.org/node/35725 Moderator: Jay D. Raman, MD, FACS Co-Hosts: Channa Amarasekera, MD; Simon Rosser, PhD, MPH LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Identify two specific surgical side effects that may be of interest to a patient who undergoes a prostatectomy (e.g. ED treatment efficacy for anal penetration, climactur...

Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment(2022) CME Available: https://auau.auanet.org/node/36065 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Discuss new FDA approved checkpoint inhibitors for treatment and counseling of advanced renal cell carcinoma. 2. Identify indications, risks and benefit of neoadjuv...

Contemporary Pharmacotherapy for OAB 2022: Monotherapy and Combined Pharmacotherapy to Optimize Treatment (2022) CME Available: https://auau.auanet.org/node/36028 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Define the similarities and differences between the various oral pharmacotherapies for OAB. 2. Review the principles of physiology and pharmacotherapy...

Controversies, Confusion, and the Future of Urologic Post-Operative Opioid Prescribing Reduction Strategies CME Available: https://auau.auanet.org/node/35160 Course Director: Jennifer Robles, MD, MPH Faculty: Chad Brummett, MD; Gregory Auffenberg, MD, MS; Hitya Abraham, MD; Kevan Sternberg, MD After participating in this activity, learners will be able to: 1. Identify at least one non-pharmaceutic...

Difficult Cases in High-Risk Bladder Cancer: An Evidence-Based Approach (2022) CME Available: https://auau.auanet.org/node/36020 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Identify low, intermediate and high risk non-muscle invasive bladder cancer (NMIBC) 2. Recommend treatment for NMIBC based on risk stratification. 3. Identify bacillus Calmette-Guérin...

The Changing Face of Advanced Prostate Cancer 2022(2022) CME Available: https://auau.auanet.org/node/36010 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Identify and treat a patient with new diagnosed M1 prostate cancer with androgen deprivation therapy (ADT) plus be able to offer additional therapies that extend survival. 2. Recognize high volume new M1 pr...

Host: Jay D. Raman, MD, FACS Guest: Akanksha Mehta, MD, MS For more information or to subscribe to the AUA Update Series, please visit: AUAnet.org/University

Diversity Equity and Inclusion in Urology: What Do We Need to Know? CME Available: https://auau.auanet.org/node/35746 LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Identify the different forms of racism and, more importantly, identify their own subconscious personal bias. 2. Identify the impact of race on medical education, research and clinical care. 3....

Should I Order a PET Scan? Integrating Molecular Imaging Into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities CME Available: https://auau.auanet.org/node/36003 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Analyze the best available evidence on the current diagnostic imaging options for prostate, kidney and urothelial cancer...

CME Available: https://auau.auanet.org/node/35793 Course Director: Amy Krambeck, MD Faculty: Dean Elterman, MD; Steven Kaplan, MD; Lori Lerner, MD ACKNOWLEDGEMENTS This educational activity is supported by independent educational grants from: Cook Medical Olympus Corporation of the Americas LEARNING OBJECTIVES At the conclusion of the activity, participants will be able to: 1. Identify the role of...

CME Available: https://auau.auanet.org/node/35710 Course Director: Stephen A. Boorjian, MD Faculty: Leonard G. Gomella, MD, FACS; David F. Jarrard, MD; Alicia K. Morgans, MD, MPH ACKNOWLEDGMENTS: This educational activity is supported by independent education grants from: Astellas AstraZeneca Merck & Co., Inc. Pfizer, Inc. At the conclusion of the activity, participants will be able to: LEARNING O...

CME Available: https://auau.auanet.org/node/35599 Course Director: David A. Ginsberg, MD Faculty: Anne P. Cameron, MD, FRCSC, FPMRS; Sara M. Lenherr, MD, MS, FPRMS, Eric Rovner, MD; Eric Rovner, MD ACKNOWLEDGEMENTS This educational activity is supported by an independent educational grant from: Urovant LEARNING OBJECTIVES At the conclusion of the activity, participants will be able to: 1. Define t...